$Clearside Biomedical (CLSD.US)$ NEWS Clearside Biomedical A...
NEWS
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
Clearside Biomedical announced that the journal RETINA has published new consensus guidelines for drug delivery via suprachoroidal space (SCS) injection. These guidelines, co-authored by 16 retinal physicians, detail best practices for SCS injection, including patient preparation, injection techniques, and post-injection care. This publication supports the use of Clearside's SCS Microinjector, which is already FDA-approved for uveitic macular edema and used in six ongoing clinical trials for various retinal diseases. Clearside's President, George Lasezkay, and Chief Medical Officer, Victor Chong, emphasized the clinical acceptance and adoption of their delivery platform.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1171Followers
73Following
8193Visitors
Follow
MARKET-TEST-DUMMY : I keep finding you in my screeners
Jaguar8 OP MARKET-TEST-DUMMY : This stock?
MARKET-TEST-DUMMY Jaguar8 OP : This is one of many I've seen you on recently when running screener
Jaguar8 OP MARKET-TEST-DUMMY :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")